Assays for heparin-induced thrombocytopenia

Area of Science:

• Immunology
• Hematology
• Clinical Diagnostics

Background:

• Heparin-induced thrombocytopenia (HIT) diagnosis relies on detecting heparin-dependent antibodies (heparin-Ig).
• Early diagnostic tests, like serotonin release assays, faced limitations in adoption due to complexity and radioactivity.
• Platelet aggregation tests, while common, exhibit lower sensitivity and specificity for heparin-Ig detection.

Purpose of the Study:

• To review the evolution and current landscape of laboratory tests for heparin-dependent antibodies (heparin-Ig).
• To highlight advancements in diagnostic methodologies for heparin-induced thrombocytopenia (HIT).
• To underscore the need for improved assays for earlier and more accurate HIT diagnosis.

Main Methods:

• Review of historical and contemporary laboratory assays for heparin-dependent antibodies (heparin-Ig).
• Discussion of platelet aggregation/activation assays, immunoglobulin binding assays, and PF4/heparin EIA.
• Analysis of test performance characteristics, including sensitivity, specificity, and clinical utility.

Main Results:

• The serotonin release assay demonstrated superior performance but limited adoption; platelet aggregation tests are more common.
• Assays detecting immunoglobulin binding to platelets are challenged by high baseline platelet-associated immunoglobulin levels.
• The PF4/heparin EIA assay avoids platelet-related issues and can differentiate IgM from IgG heparin-Ig, improving diagnostic potential.

Conclusions:

• Current laboratory diagnosis of heparin-Ig remains inexact, necessitating further improvements.
• Combining PF4/heparin EIA with platelet activation or antibody binding assays may enhance sensitivity and specificity.
• Earlier and more accurate laboratory assays for heparin-Ig are vital for managing HIT, a condition with significant morbidity and mortality.